http://albusscientia.com/index.php/home <p style="font-weight: 400;"><em>Albus Scientia </em>aims to provide a platform to the researchers who intends to publish their work in a quality journal with an efficient peer review system. The journal accepts the full-length research articles, review articles, letters to editor, short communications, and commentaries in the domain of “life sciences, health sciences and biomedical science” that includes but not limited to Animals and Plant Sciences, Biochemistry, Bioinformatics, Biotechnology, Botany, Cell biology, Developmental Biology, Environmental Sciences, Health, and Epidemiology Concepts in Human, Hematology, Immunology, Medical Sciences, Microbiology, Molecular Biology, Molecular Genetics, Molecular Systematics and Evolution, Nanobiology, Proteins and Proteomics, Physiology, Structure Biology, Toxicity, Virology, Veterinary Sciences, Zoology.</p> en-US editor.in.chief@albusscientia.com (Prof. Dr. N. Sheikh) muddygcs@gmail.com (Dr. MH Abbasi) Wed, 06 Mar 2024 23:15:50 +0000 OJS 3.3.0.11 http://blogs.law.harvard.edu/tech/rss 60 http://albusscientia.com/index.php/home/article/view/46 <div><span class="s4">The FDA alerts to potential T cell malignancy risks linked to CAR T therapies targeting CD19/BCMA, recognizing their advantages but advocating vigilant monitoring. Influential factors in secondary T cell malignancy encompass viral vectors, CAR design, and patient genetics. Analytical findings highlight instances of T cell cancer, stressing the necessity for prolonged safety studies and refined CAR T strategies. Global collaboration is crucial for consistent reporting and adherence to treatments. Recommendations include extended safety assessments, refined CAR T strategies, enhanced data reporting, and global cooperation. This viewpoint addresses safety concerns regarding CAR T therapies and proposes measures to enhance their safety and effectiveness. The discussion emphasizes the importance of optimizing CAR T strategies to minimize risks and elevate treatment outcomes</span></div> Ali Afzal, Muhammad Babar Khawar Copyright (c) 2024 Ali Afzal, Muhammad Babar Khawar https://creativecommons.org/licenses/by-nc/4.0 http://albusscientia.com/index.php/home/article/view/46 Tue, 05 Mar 2024 00:00:00 +0000